Lifecome Biochemistry Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Cash & Equivalents	96.01	55.6	24.8	84.38	23.76	97.5
Cash & Short-Term Investments	96.01	55.6	24.8	84.38	23.76	97.5
Cash Growth	678.64%	124.20%	-70.61%	255.14%	-75.63%	-49.81%
Accounts Receivable	57.58	42.64	76.83	128.42	60.06	44.86
Other Receivables	4.85	9.35	17.52	59.82	2.76	19.56
Receivables	62.43	51.99	94.36	188.24	62.82	64.42
Inventory	79.25	95.48	95.71	201.89	89.06	61.2
Other Current Assets	5.38	4.62	1.36	3.87	330.16	4.86
Total Current Assets	243.07	207.68	216.22	478.39	505.8	227.97
Property, Plant & Equipment	464.31	474.44	1,062	1,150	633.54	907.87
Long-Term Investments	31.55	32.46	51.65	44.75	48.57	59.14
Goodwill	-	-	-	61.6	-	-
Other Intangible Assets	20.79	21.08	125.58	132.21	31.4	40.86
Long-Term Deferred Tax Assets	11.42	11.42	11.05	30.96	7.47	9.15
Long-Term Deferred Charges	0	0.02	12.49	0.8	0.19	2.03
Other Long-Term Assets	2.57	1.62	12.49	66.79	12.9	11.39
Total Assets	773.72	748.71	1,492	1,965	1,240	1,258
Accounts Payable	83.8	102.52	315.72	310.09	136.11	167.7
Accrued Expenses	3.67	7.2	17.12	12.56	7.95	9.79
Short-Term Debt	161.16	306.72	296.76	387.77	202.93	156.28
Current Portion of Long-Term Debt	162.36	170.83	479.08	85.47	41.71	37.16
Current Portion of Leases	-	-	4.36	1.31	0.08	0.07
Current Income Taxes Payable	1.57	-	-	-	-	-
Current Unearned Revenue	4.45	4.92	17.06	1.51	2.81	0.91
Other Current Liabilities	2.88	5.05	112.6	131.61	93.54	18.42
Total Current Liabilities	419.89	597.24	1,243	930.31	485.14	390.34
Long-Term Debt	45	30	133.92	490.25	105.88	96.99
Long-Term Leases	-	-	35.47	121.9	45	30.69
Long-Term Unearned Revenue	1.84	1.94	30.02	3.47	4.32	9.63
Long-Term Deferred Tax Liabilities	-	-	3.46	4.96	0.22	8.73
Other Long-Term Liabilities	235.87	54.6	70.63	-	-	-
Total Liabilities	702.61	683.78	1,516	1,551	640.56	536.38
Common Stock	155.42	155.42	155.42	155.42	155.42	155.42
Additional Paid-In Capital	576.74	576.51	349.47	345.46	340.47	340.47
Retained Earnings	-663.04	-669.15	-538.36	-93.5	128.32	250.26
Treasury Stock	-	-	-	-	-32.43	-32.43
Comprehensive Income & Other	0.41	0.41	7.2	3.91	3.91	3.91
Total Common Equity	69.52	63.18	-26.27	411.29	595.69	717.63
Minority Interest	1.6	1.75	1.73	2.82	3.61	4.4
Shareholders' Equity	71.11	64.93	-24.54	414.11	599.3	722.02
Total Liabilities & Equity	773.72	748.71	1,492	1,965	1,240	1,258
Total Debt	368.53	507.55	949.6	1,087	395.6	321.19
Net Cash (Debt)	-272.52	-451.94	-924.8	-1,002	-371.84	-223.7
Net Cash Per Share	-1.77	-2.92	-5.95	-6.51	-2.41	-1.46
Filing Date Shares Outstanding	152.73	155.42	155.42	155.42	153.4	153.4
Total Common Shares Outstanding	152.73	155.42	155.42	155.42	153.4	153.4
Working Capital	-176.82	-389.55	-1,026	-451.92	20.66	-162.36
Book Value Per Share	0.46	0.41	-0.17	2.65	3.88	4.68
Tangible Book Value	48.73	42.1	-151.84	217.48	564.29	676.77
Tangible Book Value Per Share	0.32	0.27	-0.98	1.40	3.68	4.41
Buildings	-	388.09	543.18	479.28	406.53	206.45
Machinery	-	579.72	890.18	657.2	585.29	310.2
Construction In Progress	-	5.52	55.9	410.78	6.2	709.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.